
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports
Matthew C. Riddle, John B. Buse, Paul W. Franks, et al.
Diabetes Care (2020) Vol. 43, Iss. 7, pp. 1378-1381
Open Access | Times Cited: 95
Matthew C. Riddle, John B. Buse, Paul W. Franks, et al.
Diabetes Care (2020) Vol. 43, Iss. 7, pp. 1378-1381
Open Access | Times Cited: 95
Showing 1-25 of 95 citing articles:
Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020
John Dennis, Bilal A. Mateen, Raphael Sonabend, et al.
Diabetes Care (2020) Vol. 44, Iss. 1, pp. 50-57
Open Access | Times Cited: 168
John Dennis, Bilal A. Mateen, Raphael Sonabend, et al.
Diabetes Care (2020) Vol. 44, Iss. 1, pp. 50-57
Open Access | Times Cited: 168
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
Katie C. Coate, Jeeyeon Cha, Shristi Shrestha, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1028-1040.e4
Open Access | Times Cited: 167
Katie C. Coate, Jeeyeon Cha, Shristi Shrestha, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1028-1040.e4
Open Access | Times Cited: 167
Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19
Franck Mauvais‐Jarvis
Diabetes (2020) Vol. 69, Iss. 9, pp. 1857-1863
Open Access | Times Cited: 161
Franck Mauvais‐Jarvis
Diabetes (2020) Vol. 69, Iss. 9, pp. 1857-1863
Open Access | Times Cited: 161
COVID-19 y diabetes mellitus: una relación bidireccional
Marcos M. Lima-Martínez, Carlos Boada, Marialaura D. Madera-Silva, et al.
Clínica e Investigación en Arteriosclerosis (2020) Vol. 33, Iss. 3, pp. 151-157
Open Access | Times Cited: 154
Marcos M. Lima-Martínez, Carlos Boada, Marialaura D. Madera-Silva, et al.
Clínica e Investigación en Arteriosclerosis (2020) Vol. 33, Iss. 3, pp. 151-157
Open Access | Times Cited: 154
Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study
Aidin Rawshani, Elin Allansson Kjölhede, Araz Rawshani, et al.
The Lancet Regional Health - Europe (2021) Vol. 4, pp. 100105-100105
Open Access | Times Cited: 113
Aidin Rawshani, Elin Allansson Kjölhede, Araz Rawshani, et al.
The Lancet Regional Health - Europe (2021) Vol. 4, pp. 100105-100105
Open Access | Times Cited: 113
Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19
Jacqueline A. Seiglie, Jesse M. Platt, Sara J. Cromer, et al.
Diabetes Care (2020) Vol. 43, Iss. 12, pp. 2938-2944
Open Access | Times Cited: 120
Jacqueline A. Seiglie, Jesse M. Platt, Sara J. Cromer, et al.
Diabetes Care (2020) Vol. 43, Iss. 12, pp. 2938-2944
Open Access | Times Cited: 120
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)
Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 100
Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 100
Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study
Jin Ge, Mark J. Pletcher, Jennifer C. Lai, et al.
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1487-1501.e5
Open Access | Times Cited: 99
Jin Ge, Mark J. Pletcher, Jennifer C. Lai, et al.
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1487-1501.e5
Open Access | Times Cited: 99
Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans
John Xie, Yuanhao Zu, Ala Alkhatib, et al.
Diabetes Care (2020) Vol. 44, Iss. 1, pp. 188-193
Open Access | Times Cited: 98
John Xie, Yuanhao Zu, Ala Alkhatib, et al.
Diabetes Care (2020) Vol. 44, Iss. 1, pp. 188-193
Open Access | Times Cited: 98
COVID-19 and diabetes: A bidirectional relationship
Marcos M. Lima-Martínez, Carlos Boada, Marialaura D. Madera-Silva, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2021) Vol. 33, Iss. 3, pp. 151-157
Closed Access | Times Cited: 97
Marcos M. Lima-Martínez, Carlos Boada, Marialaura D. Madera-Silva, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2021) Vol. 33, Iss. 3, pp. 151-157
Closed Access | Times Cited: 97
Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 Diabetes
Ashby F. Walker, Korey K. Hood, Matthew J. Gurka, et al.
Diabetes Care (2021) Vol. 44, Iss. 7, pp. 1480-1490
Open Access | Times Cited: 83
Ashby F. Walker, Korey K. Hood, Matthew J. Gurka, et al.
Diabetes Care (2021) Vol. 44, Iss. 7, pp. 1480-1490
Open Access | Times Cited: 83
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
Endothelial dysfunction in patients with COVID-19 is a key mechanism for the development of complications
I. O. Kokaeva, Yu. V. Zhernakova, N. V. Blinova
Systemic Hypertension (2023) Vol. 19, Iss. 4, pp. 37-44
Open Access | Times Cited: 19
I. O. Kokaeva, Yu. V. Zhernakova, N. V. Blinova
Systemic Hypertension (2023) Vol. 19, Iss. 4, pp. 37-44
Open Access | Times Cited: 19
Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals
Ruxing Zhao, Yujing Sun, Yongyuan Zhang, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 41
Ruxing Zhao, Yujing Sun, Yongyuan Zhang, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 41
Clinical characteristics and outcomes of COVID-19 patients with diabetes mellitus in Kuwait
Abdullah Alshukry, Mohammad Bu Abbas, Yaseen Ali, et al.
Heliyon (2021) Vol. 7, Iss. 4, pp. e06706-e06706
Open Access | Times Cited: 37
Abdullah Alshukry, Mohammad Bu Abbas, Yaseen Ali, et al.
Heliyon (2021) Vol. 7, Iss. 4, pp. e06706-e06706
Open Access | Times Cited: 37
The effect of the COVID-19 pandemic on self-management in patients with type 2 diabetics
Hediye Utli, Birgül Vural Doğru
Primary care diabetes (2021) Vol. 15, Iss. 5, pp. 799-805
Open Access | Times Cited: 33
Hediye Utli, Birgül Vural Doğru
Primary care diabetes (2021) Vol. 15, Iss. 5, pp. 799-805
Open Access | Times Cited: 33
Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study
Mark Hamer, Catharine R. Galé, G. David Batty
Metabolism (2020) Vol. 112, pp. 154344-154344
Open Access | Times Cited: 36
Mark Hamer, Catharine R. Galé, G. David Batty
Metabolism (2020) Vol. 112, pp. 154344-154344
Open Access | Times Cited: 36
Diabetic Foot Disease during the COVID-19 Pandemic
Andrew J.M. Boulton
Medicina (2021) Vol. 57, Iss. 2, pp. 97-97
Open Access | Times Cited: 31
Andrew J.M. Boulton
Medicina (2021) Vol. 57, Iss. 2, pp. 97-97
Open Access | Times Cited: 31
Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes
Xiaofan Jia, Patricia Gesualdo, Cristy Geno Rasmussen, et al.
Diabetes Technology & Therapeutics (2021)
Open Access | Times Cited: 29
Xiaofan Jia, Patricia Gesualdo, Cristy Geno Rasmussen, et al.
Diabetes Technology & Therapeutics (2021)
Open Access | Times Cited: 29
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management
Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, et al.
Current Diabetes Reviews (2021) Vol. 17, Iss. 6
Closed Access | Times Cited: 24
Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, et al.
Current Diabetes Reviews (2021) Vol. 17, Iss. 6
Closed Access | Times Cited: 24
Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages
Sandra G. Sosa‐Rubí, Jacqueline A. Seiglie, Carlos Chivardi, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 373-380
Open Access | Times Cited: 24
Sandra G. Sosa‐Rubí, Jacqueline A. Seiglie, Carlos Chivardi, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 373-380
Open Access | Times Cited: 24
A new interventional home care model for COVID management: Virtual Covid IP
Jothydev Kesavadev, Anjana Basanth, Gopika Krishnan, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 5, pp. 102228-102228
Open Access | Times Cited: 22
Jothydev Kesavadev, Anjana Basanth, Gopika Krishnan, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 5, pp. 102228-102228
Open Access | Times Cited: 22
Contrasting factors associated with COVID-19-related ICU admission and death outcomes in hospitalised patients by means of Shapley values
Massimo Cavallaro, Haseeb Moiz, Matt J. Keeling, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 6, pp. e1009121-e1009121
Open Access | Times Cited: 20
Massimo Cavallaro, Haseeb Moiz, Matt J. Keeling, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 6, pp. e1009121-e1009121
Open Access | Times Cited: 20
The change in glycaemic control immediately after COVID‐19 vaccination in people with type 1 diabetes
Adrian Heald, Mike Stedman, Linda Horne, et al.
Diabetic Medicine (2021) Vol. 39, Iss. 4
Open Access | Times Cited: 19
Adrian Heald, Mike Stedman, Linda Horne, et al.
Diabetic Medicine (2021) Vol. 39, Iss. 4
Open Access | Times Cited: 19
Anti-inflammatory effects of GLP-1 in patients with COVID-19
Saharnaz Sazgarnejad, Niloufar Yazdanpanah, Nima Rezaei
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 3, pp. 373-381
Open Access | Times Cited: 18
Saharnaz Sazgarnejad, Niloufar Yazdanpanah, Nima Rezaei
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 3, pp. 373-381
Open Access | Times Cited: 18